This Is Why New Alzheimer's drug: How much of a breakthrough is it?
Nov 30, 2022
22:02
A drug used in clinical trials has been found to slow memory loss in patients with the condition - and although lecanemab is not a cure, it has got a lot of scientists and others very excited.
On the Sky News Daily podcast, Niall Paterson speaks to Scott Mitchell, the widower of the late Dame Barbara Windsor, who died with the disease, about what the breakthrough means to his campaign to raise awareness.
Plus Tom Clarke, Sky’s science and technology editor, explores how much of a difference the drug could make and what happens next.
Senior podcast producer: Annie Joyce
Interviews producer: Alys Bowen
Podcast promotions producer: David Chipakupaku
Archiver researcher: Nelly Stefanova
Editor: Philly Beaumont
On the Sky News Daily podcast, Niall Paterson speaks to Scott Mitchell, the widower of the late Dame Barbara Windsor, who died with the disease, about what the breakthrough means to his campaign to raise awareness.
Plus Tom Clarke, Sky’s science and technology editor, explores how much of a difference the drug could make and what happens next.
Senior podcast producer: Annie Joyce
Interviews producer: Alys Bowen
Podcast promotions producer: David Chipakupaku
Archiver researcher: Nelly Stefanova
Editor: Philly Beaumont